Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital

[1]  M. Pellegrini,et al.  Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection. , 2014, Blood reviews.

[2]  Taeg S. Kim,et al.  Viral infection of the lung: Host response and sequelae , 2013, Journal of Allergy and Clinical Immunology.

[3]  H. Einsele,et al.  Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  C. Bokemeyer,et al.  Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients , 2012, Clinical & developmental immunology.

[5]  M. Boeckh,et al.  Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. , 2011, Blood.

[6]  Bin Wang,et al.  Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia , 2010, Emerging infectious diseases.

[7]  P. Moss,et al.  Immunodeficiency and immunotherapy in multiple myeloma , 2007, British journal of haematology.

[8]  M. Keating,et al.  Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients: A Retrospective Study at a Major Cancer Center , 2006, Medicine.

[9]  J. Sierra,et al.  Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  M. Boeckh,et al.  Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  L. Sticchi,et al.  Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma , 2003, European journal of haematology.

[12]  A. Bradford.  The Australian Immunisation Handbook , 2000 .

[13]  P. Musto,et al.  Vaccination against influenza in multiple myeloma. , 1997, British journal of haematology.